Comprehensive monitoring may benefit from quantitative measurement of ketone bodies (e.g., BrAce), which could be used to enhance post‐bariatric diabetes management and distinguish between types and degrees of ketoacidosis such as SGLT2‐associated euglycemic ketoacidosis and post‐surgery starvation ketoacidosis.111, 112. This evidence concerns the gene SLC5A2 and diabetes mellitus.